AAC
Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowReprints and Permissions
Right arrow Copyright Information
Right arrow Books from ASM Press
Right arrow MicrobeWorld
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Neuwirth, C.
Right arrow Articles by Kazmierczak, A.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Neuwirth, C.
Right arrow Articles by Kazmierczak, A.

 Previous Article  |  Next Article 

Antimicrobial Agents and Chemotherapy, February 2000, p. 453-455, Vol. 44, No. 2
0066-4804/00/$04.00+0
Copyright © 2000, American Society for Microbiology. All rights reserved.

Characterization of TEM-56, a Novel beta -Lactamase Produced by a Klebsiella pneumoniae Clinical Isolate

Catherine Neuwirth,1 Roger Labia,2,* Eliane Siebor,1 Andre Pechinot,1 Stephanie Madec,2 El Bachir Chaibi,2 and Antoine Kazmierczak1

Laboratoire de Bactériologie, Hôpital Universitaire du Bocage, B.P. 1542, 21034 Dijon Cedex,1 and Centre National de la Recherche Scientifique, UMR175, 6 rue de l'Université, 29000 Quimper,2 France

Received 10 May 1999/Returned for modification 18 August 1999/Accepted 5 November 1999


    ABSTRACT
Top
Abstract
Text
References

TEM-56 produced by a Klebsiella pneumoniae clinical isolate is a novel beta -lactamase of isoelectric point 6.4 that confers a moderate resistance level to expanded-spectrum cephalosporins. The amino acid sequence deduced from the corresponding bla gene showed two amino acid replacements with respect to the TEM-2 sequence: Glu-104 to Lys and His-153 to Arg. This enzyme showed catalytic properties close to those of TEM-18. Thus, TEM-56 appears as a new TEM mutant, an intermediary between TEM-18 and the extended-spectrum beta -lactamase TEM-21.


    TEXT
Top
Abstract
Text
References

In Dijon University Hospital, Dijon, France, Klebsiella pneumoniae isolates with decreased susceptibility to cephalosporins or aztreonam are submitted to epidemiological studies performed by analytical isoelectric focusing and pulsed-field gel electrophoresis (8, 14, 17). Over a 2-year period (1995 to 1996), 22 strains producing a beta -lactamase of pI 6.4 were isolated. Analysis of chromosomal DNA by pulsed-field gel electrophoresis revealed that the 22 strains were closely related according to Tenover's criteria (24). For 21 of them, a double-disk synergy test (11) was positive between clavulanic acid and cefotaxime, whereas it was considered negative for strain Kp 395. The MICs for beta -lactams of strains of the first group were similar, whereas those for the last strain differed. Kp 395 showed high MICs for penicillins and cephalothin, but the MICs were low for expanded-spectrum cephalosporins and aztreonam and similar to those seen for Escherichia coli strains producing TEM-18 (Table 1). Conversely, MICs for these agents against Kp 377 (one representative strain of the first group) were comparable to those for the TEM-3-producing strain. Clavulanic acid potentiated expanded-spectrum cephalosporins and aztreonam, but the MICs of penicillins remained high.

                              
View this table:
[in this window]
[in a new window]
  		TABLE 1.   MICs for K. pneumoniae clinical isolates Kp 395 and Kp 377 and E. coli strains producing TEM-18, TEM-2, or TEM-3

For Kp 395 and Kp 377, a plasmid of 120 kb was extracted by the method of Birnboim and Doly (4), but all conjugation experiments carried to transfer resistance failed. Transformation experiments using E. coli HB 101 or E. coli DH5a competent cells failed, too. PCR analysis was performed as described previously (16) on plasmid DNA extracted from both strains with primers J (forward, 5'-CTTATTCCCTTTTTTGCGGC-3') and E (reverse, 5'-GGTCTGACAGTTACCAATGC-3') (6) at positions 236 and 1079 of the TEM family gene beta -lactamase, respectively, with numbering according to Sutcliffe (23). The promoter region was amplified with the following primers: GOV1 (forward, 5'-ATAAAATTCTTGAAGACGAAA-3') (16) and SIE2 (reverse, 5'-AAAACTCTCAAGGATCTTACC-3') (this study) at positions -5 and 380, respectively. PCR products were sequenced with an Applied Biosystems 373A sequencer according to the manufacturer's instructions. Analysis of the sequences (Table 2) revealed that the two blaTEM genes were derived from blaTEM-2. Moreover, their promoter regions are identical to that of blaTEM-2.

                              
View this table:
[in this window]
[in a new window]
  		TABLE 2.   Nucleotide substitutions in blaTEM-2, blaTEM-21, and blaTEM-56 genes

The deduced amino acid sequences of the enzymes produced by Kp 377 and Kp 395 are reported in Table 3. The enzyme produced by Kp 377 was TEM-21 of pI 6.4 (Lys-39, Lys-104, Arg-153, and Ser-238) (2, 3, 25) and that produced by Kp 395 was a new enzyme: TEM-56 of pI 6.4 also (Lys-39, Lys-104, and Arg-153). It appears that TEM-18 (Lys-39 and Lys-104) (R. Labia and D. Sirot, personal communication), TEM-56, and TEM-3 (Lys-39, Lys-104, and Ser-238) are intermediate mutants between TEM-2 and TEM-21. Within the TEM family, Arg-153 has been found only in TEM-21 and TEM-56.

                              
View this table:
[in this window]
[in a new window]
  		TABLE 3.   Comparative kinetic parameters of beta -lactamase TEM-2 and its mutants

beta -Lactamases TEM-2, TEM-18, TEM-56, TEM-3, and TEM-21 were purified to homogeneity according to previously described methods using ammonium sulfate precipitation, ion-exchange chromatography, and size exclusion chromatography (7, 15). Kinetic constants (Table 3) were determined by computerized microacidimetry (13), at pH 7 and 37°C, in distilled water containing 85 mM NaCl. TEM-56 hydrolyzed ceftriaxone and cefotaxime moderately, but the action on cefuroxime and ceftazidime was hardly detectable, a situation very similar to that of TEM-18. Concerning penicillins, the kinetics of TEM-56 and TEM-18 were comparable to those of TEM-2. TEM-21 and TEM-3 had considerable activity for expanded-spectrum cephalosporins and low Km values for penicillins. TEM-56, TEM-21, TEM-18, and TEM-3 enzymes are susceptible to beta -lactamase inhibitors and, in some instances, more so than native TEM-2 (Table 4). Aztreonam was a poor substrate for all tested beta -lactamases (data not shown).

                              
View this table:
[in this window]
[in a new window]
  		TABLE 4.   50% inhibitory concentrations (IC50s) of beta -lactamase inhibitors for beta -lactamase TEM-2 and its mutants

TEM-18 and TEM-56 gave similar and moderate decreases in susceptibility levels of cefotaxime, ceftazidime, and aztreonam. On the contrary, TEM-21 and TEM-3 conferred a high level of resistance to expanded-spectrum cephalosporins. This indicates that the Glu-104 to Lys amino acid substitution enables the mutant to hydrolyze these cephalosporins but not enough to confer a true resistance, as already noticed in the variants obtained by site-directed mutagenesis (18, 20, 22, 27). Conversely, the substitution of Gly-238 for Ser has a key role, as already demonstrated (5, 21, 26). Concerning the His-153 for Arg amino acid substitution, comparison of TEM-56 and TEM-18, on one hand, and TEM-21 and TEM-3, on the other hand, shows that this substitution does not significantly modify the hydrolytic properties of the enzyme, as also shown by enzyme kinetics.

Comparison of a large set of class A beta -lactamase sequences (12, 19) shows that residue 153 is not conserved, but the most frequently encountered is arginine. The role of the His-153 for Arg amino acid substitution remains unclear. Often, extended-spectrum or inhibitor-resistant TEM-derived beta -lactamases may present one or a few secondary amino acid substitutions whose roles are not always elucidated. Within presently reported TEM mutant beta -lactamases, about 10 positions have been described (http://www.lahey.org/studies/webt.htm).

It is noteworthy that the first of the 22 strains producing an enzyme of pI 6.4 was Kp 395, producing TEM-56. This strain was isolated from a patient who had received multiple beta -lactam therapies, and TEM-56 was detected only once. Then Kp 377, producing TEM-21, was isolated from a patient in the same ward. This suggests that blaTEM-21, which differs from blaTEM-56 by a single base at position 914, was selected under antibiotic pressure in vivo. Then the strain spread in the ward and in other departments subsequent to patients' transfers.


    ACKNOWLEDGMENTS

C.N. and R.L. contributed equally to this work.


    FOOTNOTES

* Corresponding author. Mailing address: Centre National de la Recherche Scientifique, UMR175, 6 rue de l'Université, 29000 Quimper, France. Phone: 33-2 98 90 80 35. Fax: 33-2 98 90 80 31. E-mail: roger.labia{at}univ-brest.fr.


    REFERENCES
Top
Abstract
Text
References

1. Ambler, R. P., A. F. W. Coulson, J. M. Frère, J. M. Ghuysen, B. Joris, M. Forsman, R. C. Levesque, G. Tirabi, and S. G. Waley. 1991. A standard numbering scheme for the class A beta -lactamases. Biochem. J. 276:269-272.
2. Arlet, G., G. Brami, D. Decré, A. Filippo, O. Gaillot, P. H. Lagrange, and A. Philippon. 1995. Molecular characterisation by PCR-restriction fragment length polymorphism of TEM beta -lactamases. FEMS Microbiol. Lett. 134:203-208[Medline].
3. Arlet, G., S. Goussard, P. Courvalin, and A. Philippon. 1999. Sequences of the genes for the TEM-20, TEM-21, TEM-22, and TEM-29 extended-spectrum beta-lactamases. Antimicrob. Agents Chemother. 43:969-971[Abstract/Free Full Text].
4. Birnboim, H. C., and J. Doly. 1979. Rapid alkaline extraction procedure for screening recombinant plasmid DNA. Nucleic Acids Res. 7:1513-1523[Abstract/Free Full Text].
5. Cantu, C., III, W. Huang, and T. Palzkill. 1996. Selection and characterization of amino acid substitutions at residues 237-240 of TEM-1 beta -lactamase with altered substrate specificity for aztreonam and ceftazidime. J. Biol. Chem. 271:22538-22545[Abstract/Free Full Text].
6. Chanal, C., M. C. Poupart, D. Sirot, R. Labia, J. Sirot, and R. Cluzel. 1992. Nucleotide sequences of CAZ-2, CAZ-6, and CAZ-7 beta -lactamase genes. Antimicrob. Agents Chemother. 36:1817-1820[Abstract/Free Full Text].
7. Farzaneh, S., E. B. Chaibi, J. Péduzzi, M. Barthélémy, R. Labia, J. Blazquez, and F. Baquero. 1996. Implication of Ile-69 and Thr-182 residues in kinetic characteristics of IRT-3 (TEM-32) beta -lactamase. Antimicrob. Agents Chemother. 40:2434-2436[Abstract].
8. Gouby, A., C. Neuwirth, G. Bourg, N. Bouzigues, M. J. Carles-Nurit, E. Despaux, and M. Ramuz. 1994. Epidemiological study by pulsed-field gel electrophoresis of an outbreak of extended-spectrum beta -lactamase-producing Klebsiella pneumoniae in a geriatric hospital. J. Clin. Microbiol. 32:301-305[Abstract/Free Full Text].
9. Goussard, S., and P. Courvalin. 1991. Sequence of the genes blaT-1B and blaT-2. Gene 102:71-73[CrossRef][Medline].
10. Heffron, F., B. J. McCarty, H. Ohtsubo, and E. Ohtsubo. 1979. DNA sequence analysis of the transposon tn3: three genes and three sites involved in transposition of tn3. Cell 18:1153-1163[CrossRef][Medline].
11. Jarlier, V., M. H. Nicolas, G. Fournier, and A. Philippon. 1988. Extended broad-spectrum beta -lactam agents in Enterobacteriaceae: hospital prevalence and susceptibility patterns. Rev. Infect. Dis. 10:867-878[Medline].
12. Joris, B., P. Ledent, O. Dideberg, E. Fonzé, J. Lamotte-Brasseur, J. A. Kelly, J. M. Ghuysen, and J. M. Frère. 1991. Comparison of the sequences of class A beta -lactamases and of the secondary structure elements of penicillin-recognizing proteins. Antimicrob. Agents Chemother. 35:2294-2301[Abstract/Free Full Text].
13. Labia, R., J. Andrillon, and F. Le Goffic. 1973. Computerized microacidimetric determination of beta-lactamase Michaelis-Menten constants. FEBS Lett. 33:42-44[CrossRef][Medline].
14. Labia, R., M. Barthélémy, and J. M. Masson. 1976. Multiplicité des beta -lactamases: un problème d'isoenzymes? C. R. Acad. Sci. (Paris) 283D:1597-1600.
15. Lenfant, F., R. Labia, and J. M. Masson. 1991. Replacement of lysine 234 affects transition state stabilization in the active site of beta -lactamase TEM1. J. Biol. Chem. 266:17187-17194[Abstract/Free Full Text].
16. Mabilat, C., and S. Goussard. 1993. PCR detection and identification of genes for extended-spectrum beta -lactamases, p. 553-563. In D. H. Persing, T. F. Smith, F. C. Tenover, and T. J. White (ed.), Diagnostic molecular microbiology: principles and applications. American Society for Microbiology, Washington, D.C.
17. Neuwirth, C., E. Siébor, J. Lopez, A. Péchinot, and A. Kazmierczak. 1996. Outbreak of TEM-24-producing Enterobacter aerogenes in an intensive care unit and dissemination of the extended-spectrum beta -lactamase to other members of the family Enterobacteriaceae. J. Clin. Microbiol. 34:76-79[Abstract].
18. Palzkill, T., and D. Botstein. 1992. Identification of amino acid substitutions that alter the substrate specificity of TEM-1 beta -lactamase. J. Bacteriol. 174:5237-5243[Abstract/Free Full Text].
19. Péduzzi, J., A. Reynaud, P. Baron, M. Barthélémy, and R. Labia. 1994. Chromosomally encoded cephalosporinase of Proteus vulgaris Ro104 belongs to Ambler's class A. Biochim. Biophys. Acta 1207:31-39[CrossRef][Medline].
20. Petit, A., L. Maveyraud, F. Lenfant, J. P. Samama, R. Labia, and J. M. Masson. 1995. Multiple substitutions at position 104 of beta -lactamase TEM-1: assessing the role of this residue in substrate specificity. Biochem. J. 305:33-40.
21. Saves, I., I. Burlet-Schilt, L. Maveyraud, J. P. Samama, J. C. Promé, and J. M. Masson. 1995. Mass spectral kinetic study of acylation and deacylation during the hydrolysis of penicillins and cefotaxime by beta -lactamase TEM-1 and the G238S mutant. Biochemistry 34:11660-11667[CrossRef][Medline].
22. Sowek, J. A., S. B. Singer, S. Ohringer, M. F. Malley, T. J. Dougherty, J. Z. Gougoutas, and K. Bush. 1991. Substitution of lysine at position 104 or 240 of TEM-1 pTS18R beta -lactamase enhances the effect of serine-164 substitution on hydrolysis or affinity for cephalosporins and the monobactam aztreonam. Biochemistry 30:3179-3188[CrossRef][Medline].
23. Sutcliffe, J. G. 1978. Nucleotide sequence of the ampicillin resistance gene of Escherichia coli plasmid pBR322. Proc. Natl. Acad. Sci. USA 8:3737-3741.
24. Tenover, F. C., R. D. Arbeit, R. V. Goering, P. A. Mickelsen, B. E. Murray, D. H. Persing, and B. Swaminathan. 1995. Interpreting chromosomal DNA restriction patterns produced by pulsed-field gel electrophoresis: criteria for bacterial strain typing. J. Clin. Microbiol. 33:2233-2239[Medline].
25. Tessier, F., C. Arpin, A. Allery, and C. Quentin. 1998. Molecular characterization of a TEM-21 beta -lactamase in a clinical isolate of Morganella morganii. Antimicrob. Agents Chemother. 42:2125-2127[Abstract/Free Full Text].
26. Venkatachalam, K. V., W. Huang, M. La Rocco, and T. Palzkill. 1994. Characterization of TEM-1 beta -lactamase mutants from position 238 to 241 with increased catalytic efficiency for ceftazidime. J. Biol. Chem. 269:23444-23450[Abstract/Free Full Text].
27. Viadiu, H., J. Osuna, A. L. Fink, and X. Soberon. 1995. A new TEM beta -lactamase double mutant with broadened specificity reveals substrate-dependent functional interactions. J. Biol. Chem. 270:781-787[Abstract/Free Full Text].

Antimicrobial Agents and Chemotherapy, February 2000, p. 453-455, Vol. 44, No. 2
0066-4804/00/$04.00+0
Copyright © 2000, American Society for Microbiology. All rights reserved.


This article has been cited by other articles:


This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowReprints and Permissions
Right arrow Copyright Information
Right arrow Books from ASM Press
Right arrow MicrobeWorld
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Neuwirth, C.
Right arrow Articles by Kazmierczak, A.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Neuwirth, C.
Right arrow Articles by Kazmierczak, A.

Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
Clin. Vaccine Immunol. Clin. Microbiol. Rev.
J. Clin. Microbiol. ALL ASM JOURNALS